Munthe-Kaas, Ragnhild
Aam, Stina
Saltvedt, Ingvild
Wyller, Torgeir Bruun
Pendlebury, Sarah T.
Lydersen, Stian
Hagberg, Guri
Schellhorn, Till
Rostoft, Siri
Ihle-Hansen, Hege
Funding for this research was provided by:
Vestre Viken Hospital Trust, Norway (21C004 EARLY)
Article History
Received: 7 September 2021
Accepted: 11 February 2022
First Online: 19 February 2022
Declarations
:
: The study was approved by the Norwegian Regional Committee for Medical and Health Research Ethics (REK) North, (REC number 2015/171). All methods were performed in accordance with the relevant guidelines and regulations. Participants gave informed written consent; if unable to give consent, informed written consent was given by a family proxy.
: Not applicable
: IS was an investigator in the Boehringer-Ingelheim trial 1346.0023. The other authors have no disclosures.